非小细胞肺癌脑转移治疗进展(7)
[29] Soria J，Tan DSW，Chiari R，et al. First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer(ASCEND-4)：A randomised， open-label，phase 3 study[J]. The Lancet，2017，389(10072)：917-929.[30] Shaw AT，Kim TM，Crinò L，et al. Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib(ASCEND-5)：a randomised ......
您现在查看是摘要页，全文长 2516 字符。